Lei Guo
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 23
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 21
- Lung Cancer Research Studies 16
-
- Lung Cancer Treatments and Mutations 38
- Modeling and Simulation top 2%
- Immunology top 5%
-
- Viral Infections and Immunology Research 13
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 11
-
- Genetic factors in colorectal cancer 10
-
- Virus-based gene therapy research 9
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (8 papers)Journal of Hazardous Materials (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lei Guo
174 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Cancer Research 545
- Oncology 925
- Pulmonary and Respiratory Medicine 954
- Modeling and Simulation 122
- Immunology 470
Countries citing papers authored by Lei Guo
This map shows the geographic impact of Lei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Guo more than expected).
Fields of papers citing papers by Lei Guo
This network shows the impact of papers produced by Lei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Guo. The network helps show where Lei Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 13 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 23 | |
| 10 | 2021 | 22 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 19 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 2 | |
| 16 | 2017 | 32 | |
| 17 | 2016 | 49 | |
| 18 | 2016 | 9 | |
| 19 | [Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy]. | 2011 | 5 |
| 20 | 2003 | 30 |
About Lei Guo
Lei Guo is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 185 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (38 papers), Cancer Genomics and Diagnostics (23 papers), Cancer Immunotherapy and Biomarkers (21 papers), Lung Cancer Research Studies (16 papers), Viral Infections and Immunology Research (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Genetic factors in colorectal cancer (10 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Cancer Research (545 citations), Oncology (925 citations) and Pulmonary and Respiratory Medicine (954 citations). Lei Guo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianming Ying, Tian Qiu, Ling Shan, Yun Ling, Wenbin Li, Enshen Long, Weihua Li, Ning Lü, Shugeng Gao and Xuemin Xue. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.